225 related articles for article (PubMed ID: 29444253)
1. HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.
Raymond S; Nicot F; Carcenac R; Lefebvre C; Jeanne N; Saune K; Delobel P; Izopet J
J Antimicrob Chemother; 2018 May; 73(5):1152-1157. PubMed ID: 29444253
[TBL] [Abstract][Full Text] [Related]
2. Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.
Raymond S; Nicot F; Abravanel F; Minier L; Carcenac R; Lefebvre C; Harter A; Martin-Blondel G; Delobel P; Izopet J
J Clin Virol; 2020 Jan; 122():104229. PubMed ID: 31809945
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.
May S; Adamska E; Tang J
J Clin Virol; 2020 Jun; 127():104376. PubMed ID: 32344322
[TBL] [Abstract][Full Text] [Related]
4. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
[TBL] [Abstract][Full Text] [Related]
5. Optimization of HIV Sequencing Method Using Vela Sentosa Library on Miseq Ilumina Platform.
Papa Mze N; Fernand-Laurent C; Daugabel S; Zanzouri O; Marque Juillet S
Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397248
[TBL] [Abstract][Full Text] [Related]
6. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
[TBL] [Abstract][Full Text] [Related]
7. Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.
Bonifacio MA; Genchi C; Lagioia A; Talamo V; Volpe A; Mariggiò MA
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269868
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an
Tzou PL; Ariyaratne P; Varghese V; Lee C; Rakhmanaliev E; Villy C; Yee M; Tan K; Michel G; Pinsky BA; Shafer RW
J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29618499
[TBL] [Abstract][Full Text] [Related]
9. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.
Simen BB; Braverman MS; Abbate I; Aerssens J; Bidet Y; Bouchez O; Gabriel C; Izopet J; Kessler HH; Stelzl E; Di Giallonardo F; Schlapbach R; Radonic A; Paredes R; Recordon-Pinson P; Sakwa J; St John EP; Schmitz-Agheguian GG; Metzner KJ; Däumer MP;
J Virol Methods; 2014 Aug; 204():31-7. PubMed ID: 24731928
[TBL] [Abstract][Full Text] [Related]
10. Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq.
Dudley DM; Bailey AL; Mehta SH; Hughes AL; Kirk GD; Westergaard RP; O'Connor DH
Retrovirology; 2014 Dec; 11():122. PubMed ID: 25533166
[TBL] [Abstract][Full Text] [Related]
11. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
Nicot F; Jeanne N; Raymond S; Delfour O; Carcenac R; Lefebvre C; Sauné K; Delobel P; Izopet J
J Med Virol; 2018 Sep; 90(9):1486-1492. PubMed ID: 29750364
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
[TBL] [Abstract][Full Text] [Related]
13. Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.
Fisher RG; Smith DM; Murrell B; Slabbert R; Kirby BM; Edson C; Cotton MF; Haubrich RH; Kosakovsky Pond SL; Van Zyl GU
J Clin Virol; 2015 Jan; 62():48-53. PubMed ID: 25542470
[TBL] [Abstract][Full Text] [Related]
14. RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients.
Alidjinou EK; Deldalle J; Hallaert C; Robineau O; Ajana F; Choisy P; Hober D; Bocket L
J Antimicrob Chemother; 2017 Oct; 72(10):2823-2830. PubMed ID: 29091197
[TBL] [Abstract][Full Text] [Related]
15. Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase.
Moore HP; Palumbo PJ; Notarte KI; Fogel JM; Cummings V; Gamble T; Del Rio C; Batey DS; Mayer KH; Farley JE; Remien RH; Beyrer C; Hudelson SE; Eshleman SH;
J Clin Microbiol; 2024 Jun; 62(6):e0013624. PubMed ID: 38727213
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Automatic Analysis of Ultradeep Pyrosequencing Raw Data to Determine Percentages of HIV Resistance Mutations in Patients Followed-Up in Hospital.
Bellecave P; Recordon-Pinson P; Fleury H
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):85-92. PubMed ID: 26529549
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit.
Stelzl E; Pröll J; Bizon B; Niklas N; Danzer M; Hackl C; Stabentheiner S; Gabriel C; Kessler HH
J Virol Methods; 2011 Dec; 178(1-2):94-7. PubMed ID: 21907239
[TBL] [Abstract][Full Text] [Related]
18. Cost-efficient HIV-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: implications for use in low- and middle-income countries.
Ekici H; Rao SD; Sönnerborg A; Ramprasad VL; Gupta R; Neogi U
J Antimicrob Chemother; 2014 Dec; 69(12):3349-55. PubMed ID: 25085657
[TBL] [Abstract][Full Text] [Related]
19. Analysis of unusual and signature APOBEC-mutations in HIV-1 pol next-generation sequences.
Tzou PL; Kosakovsky Pond SL; Avila-Rios S; Holmes SP; Kantor R; Shafer RW
PLoS One; 2020; 15(2):e0225352. PubMed ID: 32102090
[TBL] [Abstract][Full Text] [Related]
20. A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.
Taylor T; Lee ER; Nykoluk M; Enns E; Liang B; Capina R; Gauthier MK; Domselaar GV; Sandstrom P; Brooks J; Ji H
Sci Rep; 2019 Jun; 9(1):8970. PubMed ID: 31222149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
